BTIS
NKTR icon

BB&T Investment Services’s Nektar Therapeutics NKTR Stock Holding History

BB&T Investment Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$119K Buy
+133
New +$78.7K 0.02% 373

Other funds holding NKTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BB&T Investment Services's NKTR Position: Q4 2017 in Review

BB&T Investment Services opened a new position in Nektar Therapeutics (NKTR) in Q4 2017: 133 shares worth $119K. The stake represents 0.02% of the portfolio and ranks #373 among its holdings.

265 funds tracked by Wall St. Rank hold NKTR as of Q4 2017.

  • BB&T Investment Services held 133 shares of Nektar Therapeutics worth $119K as of Q4 2017.
  • Nektar Therapeutics was a new BB&T Investment Services position in Q4 2017.
  • Nektar Therapeutics made up 0.02% of BB&T Investment Services's portfolio in Q4 2017, its #373 holding.
  • 265 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.